Thus, the present study is the first to address such differences through the comparison of Indian and German thymoma patients with regard to the prevalence of the thymoma-specific GTF2I mutation, clinical manifestation, paraneoplastic myasthenia gravis and histology. The gene discussed is GTF2I; the disease is myasthenia gravis.